CARDEA: Auditable Reasoning Grounded in Spatial Evidence for End-to-End Coronary Angiography Interpretation
为解决冠状动脉造影解读一致性问题,开发了CARDEA模型,通过视觉特征对齐、自蒸馏和强化学习方法提供可审计的推理过程。
为解决冠状动脉造影解读一致性问题,开发了CARDEA模型,通过视觉特征对齐、自蒸馏和强化学习方法提供可审计的推理过程。
To address factual hallucinations and opaque reasoning in multimodal models for gastrointestinal (GI) pathology image diagnosis, this work introduces the first large-scale GI pathology dataset annotated with explicit clinical reasoning chains. We propose a “prompt-argumentation” strategy that jointly optimizes lesion classification and anatomical localization, and design a Grouped Relative Policy Optimization (GRPO) framework integrating vision-language modeling with structured prompt engineering. Built upon supervised fine-tuning, GRPO enhances reasoning auditability via intra-group consistency optimization. Experiments on real-world pathology report generation demonstrate that our method achieves a 18.7% improvement in clinical relevance, a 32.4% increase in structural completeness, and a 41.2% reduction in diagnostic error rate over state-of-the-art baselines—significantly advancing model accuracy, trustworthiness, and clinical utility.
为解决冠状动脉造影解读一致性问题,开发了CARDEA模型,通过视觉特征对齐、自蒸馏和强化学习方法提供可审计的推理过程。
To address factual hallucinations and opaque reasoning in multimodal models for gastrointestinal (GI) pathology image diagnosis, this work introduces the first large-scale GI pathology dataset annotated with explicit clinical reasoning chains. We propose a “prompt-argumentation” strategy that jointly optimizes lesion classification and anatomical localization, and design a Grouped Relative Policy Optimization (GRPO) framework integrating vision-language modeling with structured prompt engineering. Built upon supervised fine-tuning, GRPO enhances reasoning auditability via intra-group consistency optimization. Experiments on real-world pathology report generation demonstrate that our method achieves a 18.7% improvement in clinical relevance, a 32.4% increase in structural completeness, and a 41.2% reduction in diagnostic error rate over state-of-the-art baselines—significantly advancing model accuracy, trustworthiness, and clinical utility.